Archive for 2002

Cultivating Prosperous Partnerships

Cultivating Prosperous Partnerships Like dedicated gardeners — who know that it’s not enough to merely plant seeds and bulbs to create a flourishing landscape — pharmaceutical companies have come to realize that tending to their partnering relationships is critical to achieving the best results.



Pa. uses tobacco settlement to fund biotech

Pa. uses tobacco settlement to fund biotech Its efforts reflect a larger trend of states targeting bioscience as a source of future jobs and revenue. Overall, at least 41 states have instituted initiatives in recent years to attract new life-sciences companies, according to research conducted by Columbus, Ohio-based nonprofit organization Battelle Memorial Institute



Veteran biotech investors offer tips from trenches

Veteran biotech investors offer tips from trenches These market-hardened biotech investors made three basic recommendations: be patient, take profit when you can, and don’t believe hype. Although this may sound like Investing 101, their lessons have the added credibility of being based on real life.



As Pipelines Wither, Pharma and FDA Explore Whether Microarrays are Ready for Primetime

As Pipelines Wither, Pharma and FDA Explore Whether Microarrays are Ready for Primetime When can the pharmaceutical industry start trusting the technology? When should it make the leap from investigative, experimental technique to industry standard? And should the FDA start using microarray data to make critical decisions about the safety and efficacy of new drugs?



%d bloggers like this: